Aquilo Capital invests in drug development companies that harness the power of cutting-edge science to address urgent medical needs. We employ deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. In our view, these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society. Marc Schneidman, Founder & CIO, has over 20 years of dedicated investing experience across the biotechnology universe.
Company Details
- Employees
- 3
- Address
- San Francisco, Ca
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- aquilocapitalmanagement.com
- Keywords
- Chicago.
- HQ
- San Francisco, CA
Aquilo Capital Management Questions
Aquilo Capital Management's website is aquilocapitalmanagement.com
Aquilo Capital Management's LinkedIn profile is https://www.linkedin.com/company/aquilo-capital-l.p.
Aquilo Capital Management has
3 employees.
View email and phone details for 3
employees at Aquilo Capital Management.
Aquilo Capital Management's industry is
Investment Management
Aquilo Capital Management's top competitors are
Kcap Biotechnology Fund Lp,
Aisling Capital,
Ecor1 Capital, Llc,
Aquilo Partners, L.p.,
Orbimed,
Spruce Street Capital Lp,
Novo Holdings,
Amoon Fund,
Tcgx,
Gresham Partners.
Aquilo Capital Management's categories are Investment Management
